What is King Pharmaceuticals's total debt?

King Pharmaceuticals (KG) reported total debt of $176.72M in Q1 2026.

What does total debt mean?

Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.

King Pharmaceuticals KG Total debt

Total debt at other companies

SiriusPointSPNT

$702.9M+2.2%

Selective Insurance GroupSIGI

$904.33M-0.5%

Reinsurance Group of AmericaRGA

$7.41B+5.3%

Arch Capital GroupACGL

——

Tiptree Inc.TIPT

——

Verisk Analytics, Inc.VRSK

——

Other financials

Income statement

See full

Revenue$10.2M+1,112%

Net income-$7.4M-1,786%

EPS (diluted)-$0.96-586%

Balance sheet

See full

Cash & equivalents$62.2M+1,724%

Total equity$121.4M+2,773%

Total assets$964.2M—

Cash flow

See full

Operating cash flow-$15.1M-1,628%

Valuation

See full

Market cap$70.42M-71.3%

Enterprise value$184.93M-52.3%

P/E1.2×—

P/S1.6×-27.7×

Profitability

See full

Net margin131.5%—

Returns & leverage

See full

Return on equity90.8%—

Debt / equity1.5×—

Where this comes from

Calculated from King Pharmaceuticals’s reported figures.

$174.7Mlong term debt=$176.72M

Plus components not separately reported this period.

The official record: King Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is King Pharmaceuticals's total debt?: King Pharmaceuticals (KG) reported total debt of $176.72M in Q1 2026.
What does total debt mean?: Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.